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Abstract Extracts of the adult worms of both Schistosoma
mansoni and Schistosoma haematobium can metabolise some
typical P450 substrates but to differing degrees. S. mansoni
worm extracts displayed a V12-fold higher specific activity
for an aminopyrine substrate than rat liver microsomes. At
4 mM substrate concentration the demethylation reaction with
N-nitrosodimethylamine (NDMA) (5 nmol HCHO/mg protein/
min) was only half that of rat liver microsomes, whereas in
extracts of S. haematobium, no detectable activity was found
towards NDMA. Using ethylmorphine as substrate the
demethylation activity of S. mansoni extracts (1.82 nmol
HCHO/mg protein/min) was 5.5-fold lower than that of rat
liver microsomes. Benzphetamine demethylase activity was also
readily detectable in S. mansoni worm extracts at 6.79 nmol
HCHO/mg protein/min compared with 10.20 nmol HCHO/mg
protein/min in the case of rat liver microsomes. When aniline
was used as substrate, surprisingly, no activity was found in
worm extracts of either S. mansoni or S. haematobium, whereas
rat liver microsomes showed high activity towards this amine.
The anti-P450 2E1 and 2B1/2 cross-reacted with both worm
homogenates and gave a specific band corresponding to a
protein of molecular weight of V50.0 kDa. A study with anti-
P450 IVA antibody revealed that while this protein was strongly
expressed in S. haematobium worm extracts, no immunoreac-
tivity was observed with extracts of S. mansoni. Immunoblotting
analyses with anti-P450 IIIA and P450 1A1 did not detect
immunoreactive protein in either S. mansoni or S. haemato-
bium. 7 2002 Published by Elsevier Science B.V. on behalf of
the Federation of European Biochemical Societies.
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1. Introduction
Adult schistosome worms inhabit host blood vessels and
have evolved a number of strategies to survive in this aerobic
environment, rendering them invulnerable to the host immune
system. Among the enzymes that play an important role in
parasite survival is the phase II drug-metabolising enzyme
glutathione S-transferase which is involved in the detoxi¢ca-
tion of xenobiotics, including the antischistosomal drug di-
chlorvos [1]. The parasite’s anti-oxidant enzyme system may
also play a key role in allowing adult Schistosoma mansoni
and Schistosoma haematobium worms to tolerate oxyradical
attack from activated macrophages [2] and granulocytes [3].
Investigation of the metabolising systems present in adult
worms has shown that superoxide dismutase, glutathione per-
oxidase, glutathione S-transferase, tripeptide glutathione, and
a cytochrome c peroxidase-linked activity are present [3], but
so far cytochrome (CYP) P450 activities have not been re-
ported. CYP-P450 proteins are the products of a gene super-
family of haem-binding monooxygenases found in many di-
verse species [4]. They are well documented, particularly in
vertebrates, but little is known of P450 genes in blood para-
sites of the genus Schistosoma.
Since the adult S. mansoni worms live in the inferior mes-
enteric venous system where they are potentially exposed to
the same toxic substances that reach the liver, a parasite P450
system would be expected to play a role in the survival of the
parasite within the host environment. In this present study a
functional P450 system was identi¢ed in adult worms of both
S. mansoni and S. haematobium.
2. Materials and methods
2.1. Schistosome worms
Schistosomes used in this study were as follows: adult worms of
S. mansoni (Puerto Rico isolate) and S. haematobium were obtained
from life cycles maintained, respectively, in TO mice and Syrian gold-
en hamsters at the School of Biological Science, University of North
Wales, Bangor, UK.
2.2. Lymphocytes
Whole blood was collected from BDF1 (C57BL/DBA) mice under
terminal anaesthesia by cardiac puncture into universal vials contain-
ing 200 Wl 0.5 M EDTA. Vials were centrifuged at 800Ug for 10 min,
the bu¡y coat was harvested and then resuspended in 10 ml of 0.16 M
ammonium chloride. The resuspended white cells were mixed to lyse
any residual erythrocytes and centrifuged immediately at 800Ug for
8 min. The pellet was then resuspended in ice-cold 100 mM potassium
phosphate bu¡er, pH 7.4 and homogenised using a glass homogeniser.
2.3. Antibodies
A mouse monoclonal anti-rat P450 2E1, 1-98-1, was a gift from
Prof. H. Gelboin and Dr Kris Krausz, Laboratory of Molecular Car-
cinogenesis, National Institute of Health, Bethesda, MD, USA. Anti-
P450s 2B1/2, 1A1, IIIA and IVA (polyclonal anti-rat) were purchased
from Amersham International (Amersham, UK).
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2.4. Sample preparation
Outbred Wistar rat liver and hamster liver microsomes were pre-
pared according to Mostafa et al. [5]. Livers were removed immedi-
ately after decapitation, chilled on ice, washed with 100 mM potas-
sium phosphate bu¡er, pH 7.4 and homogenised in three volumes
(w/v) of the same bu¡er. The crude homogenate was centrifuged at
10 000Ug for 10 min and the supernatant fraction was further centri-
fuged at 100 000Ug for 1 h, both at 4‡C to yield the microsomal
pellet. This was then resuspended in 100 mM potassium phosphate
bu¡er pH 7.4 and used for assays of enzymatic activity and for im-
munoblotting studies of P450 proteins. Microsomes were also pre-
pared from rats exposed to 5% (v/v) ethanol for 3 days or to 0.05%
(w/v) phenobarbital for 1 week both via the drinking water to induce,
respectively, CYP2E1 [6] or CYP2B1/2 [7]. Pregnenolone 16K-carbo-
nitrile-, clo¢brate- and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-
induced microsomes were purchased from Amersham International.
Preparation of worm extracts: male and female adult S. mansoni
and S. haematobium worms were homogenised with ice-cold 100 mM
potassium phosphate bu¡er, pH 7.4. The crude homogenates were
centrifuged at 10 000Ug for 10 min and the supernatant at
100 000Ug for 1 h at 4‡C exactly as described above for the liver
microsomes. It was found that the P450 activity towards N-nitroso-
dimethylamine (NDMA) was four- to ¢ve-fold higher in the 10 000Ug
and this supernatant was used for all subsequent enzyme assays and
immunoblotting analyses.
2.5. Functional assays of cytochrome P450
Aminopyrine, NDMA, ethylmorphine and benzphetamine de-
methylase activities were assayed according to El-Amri et al. [8] and
Yang et al. [6] and the amount of formaldehyde formed was deter-
mined by the method of Nash [9]. The assay mixture (0.5 ml) con-
tained 50 mM Tris^HCl, pH 7.4, 10 mM MgCl2, 150 mM KCl,
NADPH-generating system (0.4 mM NADPþ, 10 mM glucose
6-phosphate, and 0.8 U glucose-6-phosphate dehydrogenase) and rat
liver microsomes as a positive control or Schistosoma worm extract
with one of the following substrates: 4 mM aminopyrine or NDMA
and ethylmorphine (1 mM), or benzphetamine (2 mM). The reaction
components were preincubated at 37‡C prior to initiating the reaction
by the addition of the relevant substrate and the reaction was carried
out for 30 min; blanks were prepared by omitting the NADPH-gen-
erating system. A unit of activity was de¢ned as 1 nmol HCHO/mg
protein/min.
Dealkylation reactions (ethoxy- and pentoxyresoru¢n O-dealkylase
activity) were carried out according to Wardlaw et al. [10] and were
quantitated by measurement of increased resoru¢n £uorescence with
time. Reactions were carried out in a total volume of 1.2 ml and
microsomal protein or Schistosoma worm extracts were added to
0.1 M potassium phosphate bu¡er pH 7.6 together with 2 WM ethoxy
or pentoxyresoru¢n (Sigma, Poole, UK). The substrate^microsome
solution was then incubated for 2 min at 37‡C prior to initiation of
the reaction with 0.5 mM NADPH (Sigma). The dealkylation reaction
was allowed to proceed for 10^15 min at 37‡C and then was termi-
nated by the addition of 2 ml of cold methanol. A unit of activity was
de¢ned as 1 pmol resoru¢n/mg protein/min.
Aniline hydroxylase activity was assayed according to Imai et al.
[11] by following the formation of p-aminophenol from aniline. The
reaction mixture contained 8 mM aniline, 0.32 mM NADP, 3 mM
glucose 6-phosphate, 2.5 mM MgCl2, 1.3 U of glucose-6-phosphate
dehydrogenase, 8.0 mM nicotinamide, 100 mM Tris^HCl bu¡er, pH
8.0, and measured amounts of S. mansoni and S. haematobium worm
extract; rat liver microsomes were also assayed as a positive control.
Reactions were carried out for 30 min at 37‡C. A unit of activity was
de¢ned as 1 Wmol p-aminophenol liberated/mg protein/min.
NADPH-cytochrome P450 reductase was measured according to
Yasukochi et al. [12]. The assay mixture contained 2 mM NADPH,
0.8 mM cytochrome c and 375 mM potassium phosphate bu¡er pH
7.7 and reactions were performed at 37‡C for 10 min. The activity was
calculated using the molar absorption coe⁄cient of 550 nm=21
mM31 cm31. A unit of reductase activity is 1 Wmol of cytochrome c
reduced/Wg protein/min.
2.6. Protein analysis
Total protein concentrations of schistosome extracts and of rat liver
microsomes were assayed by the method of Bradford [13] using a
calibration curve established with bovine serum albumin as a stan-
dard. Proteins in these preparations were analysed by SDS^PAGE on
10% gels according to the method of Laemmli [14]. The gel proteins
were then transferred by electroblotting to a nitrocellulose membrane
(High bond C-extra, Amersham) according to Towbin et al. [15]. Im-
munoreactive proteins were detected using enhanced chemilumines-
cence (ECL Kit, Amersham International).
3. Results
3.1. Functional assays
In order to detect the presence of P450 protein and to
de¢ne the common P450 subclasses in schistosomal worm ex-
tracts, di¡erent P450 substrates were used. Extracts of S. man-
soni and S. haematobium showed detectable, protein concen-
tration-dependent N-demethylation activity, which for
S. mansoni was approximately 12-fold higher for aminopyrine
demethylation than for rat liver microsomes (9.3 versus
0.76 nmol HCHO/mg protein/min). In the case of S. haema-
tobium, the calculated speci¢c activity was 2.58 nmol HCHO/
mg protein/min, which is three times higher than that of rat
liver microsomes and four times less than determined for
S. mansoni extract (Table 1).
At 4 mM NDMA the speci¢c activity of the demethylase
activity for the S. mansoni extract (4.9 nmol HCHO/mg pro-
tein/min) was about half that of rat liver microsomes (7.6 nmol
HCHO/mg protein/min) (Table 1). Surprisingly, extracts of
S. haematobium displayed no NDMA demethylase activity
when assayed under identical conditions.
The ethylmorphine deethylase activity of a S. mansoni
worm extract showed a protein-dependent increase in activity
which was 5.5-fold lower than that of rat liver microsomes.
Benzphetamine demethylase activity was also readily detect-
able in the S. mansoni worm extract but was 1.5-fold lower
Table 1
Summary of the functional assays for P450 in S. mansoni, S. haematobium and acetone-induced rat liver microsomes (positive control)
Substrate used Speci¢c P450 Substrate concentration Speci¢c activity
S. mansoni S. haematobium Rat liver microsomes, acetone-induced
Aminopyrinea 2E1 4.0 mM 9.30 2.58 0.76
NDMAa 2E1 4.0 mM 4.97 N.D. 7.65
Ethylmorphinea 2E1 1.0 mM 1.82 ^ 9.95
Benzphetaminea 2E1 2.0 mM 6.79 ^ 10.20
Anilineb 2E1 8.0 mM N.D. N.D. 3.50
Pentoxyresoru¢nc 2B1 and 2B2 1.5 pM 70.32 ^ 22.20
Ethoxyresoru¢nc 1A1 and 1A2 2.0 pM N.D. N.D. 88.86
aFor aminopyrine, NDMA, ethylmorphine, and benzphetamine, the speci¢c activity is expressed as nmol HCHO/mg protein/min.
bFor aniline hydroxylase the speci¢c activity is expressed as Wmol p-aminophenol liberated/mg protein/min.
cFor pentoxy- and ethoxyresoru¢n, the speci¢c activity is expressed as pmol resoru¢n/mg protein/min.
N.D.: not detected.
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than that of rat liver microsomes (i.e. 6.79 versus 10.20 nmol
HCHO/mg protein/min, Table 1).
Hydroxylase activity was not detectable using aniline as a
substrate at 8 mM concentration, in either S. mansoni or
S. haematobium worm extracts, whereas rat liver microsomes
showed a relatively high hydroxylase activity (3.5 Wmol ami-
nophenol/mg protein/min) when assayed under identical con-
ditions (Table 1).
The speci¢c activity for pentoxyresoru¢n dealkylase activity
for the S. mansoni worm extract was three-fold higher (70.32
versus 22.20 pmol resoru¢n/mg protein/min) than that of rat
liver microsomes (Table 1), but showed no detectable ethoxy-
resoru¢n dealkylation when assayed at the same time as rat
liver microsomes, which showed very high speci¢c activity
(88.86 pmol resoru¢n/mg protein/min).
NADPH-cytochrome P450 reductase was measured using
an indirect method for detection of general broad-range
P450 activity. Both S. mansoni and S. haematobium worm
extracts showed clear evidence of P450 reductase activity
that increased with protein concentration in the assay. This
reductase activity was much lower than that of rat liver micro-
somes (10.0 Wmol cytochrome c reduced/mg protein/min for
S. mansoni versus 147.8 for rat liver microsomes). For the
S. haematobium worm extract, P450 reductase activity was
evident at 3.5 Wmol cytochrome c reduced/mg protein/min.
3.2. Immunoreactivity
To complement the ¢ndings obtained using in vitro activity
assays, di¡erent anti-P450 antibodies were used to detect the
presence of P450 in S. mansoni and S. haematobium worm
extracts employing SDS^PAGE. These results and the indi-
vidual observations are detailed as follows. Anti-P450 2E1
cross-reacted with both worm extracts, giving in each case a
speci¢c band which corresponded to a protein with a molec-
ular weight ofV52 000 Da and similar to the one observed in
rat liver microsomes (Fig. 1A).
Immunoblotting analysis of both S. mansoni (Fig. 1B) and
S. haematobium (Fig. 1C) worm extracts with anti-P450 2B1/2
revealed that both contained a protein that was strongly im-
munoreactive with this antibody and which also had a molec-
ular weight of V52 000 Da. As expected, uninduced rat liver
microsomes and uninduced hamster liver microsomes (Fig.
1D) showed no cross-reactivity with this antibody (2B1/2).
Immunoblotting analysis with anti-P450 IA (Fig. 1E) anti-
body failed to detect immunoreactive protein in either S. man-
soni or S. haematobium worm homogenates. Similarly no
antigen was detected in either of these worm extracts when
anti-P450 IIIA was used (Fig. 1F). Both proteins were assayed
under conditions that readily allowed detection of the induced
protein in rat liver microsomes (Fig. 1E,F).
No immunoreactivity was obtained with S. mansoni worm
supernatant using anti-P450 IVA antibody (Fig. 1G) whereas
strong cross-reactivity was obtained with S. haematobium
worm supernatant (Fig. 1H), indicating that this form of
P450 may be strongly expressed in S. haematobium adult
worms. This implies a clear distinction in the expression pro-
¢le of a P450 IVA-like protein between the two worm species.
In each case a strong signal was detected in clo¢brate-induced
rat liver microsomes. The protein identi¢ed in the S. haema-
tobium worm extracts appeared to be of lower molecular
weight than the rat equivalent.
One potential concern relating to the analysis of enzymatic
functions of protein expression in worms obtained by liver
perfusion is that some or all of the activities assayed could
be accounted for, either by contamination from ingested host
white blood cells or by contamination from traces of host
liver. Therefore, immunoblotting analyses of uninduced rat
and hamster liver microsomes and lymphocyte extracts were
carried out (Figs. 1I,J). In all cases no immunoreactive protein
was obtained with the anti-rabbit P450 2B1/2 and anti-rat
P450 2E1 antibodies that reacted strongly with both types
of schistosomal worm homogenates. These results indicated
that contamination from either the blood of the host organ-
ism or the liver was extremely unlikely to account for the data
produced using worm extracts.
Fig. 1. Western blot analyses of adult schistosome worm homoge-
nates and rodent liver microsomes (rlm) using anti-P450 proteins.
A: Anti-P450 2EI: lanes 1^3, S. haematobium, S. mansoni and unin-
duced rat liver microsomes (rlm) (25 Wg protein/lane), respectively.
B: Anti-P450 2B1/2: lanes 1^4, S. mansoni and lane 5 uninduced
rlm (25 Wg protein/lane). C: Anti-P450 2B1/2: lanes 1 and 2, S. hae-
matobium, lane 3, blank and lane 4, uninduced rlm (30 Wg protein/
lane). D: Anti-P450 2B1/2: lane 1, phenobarbital-induced rlm (5 Wg
protein), and lanes 2^4, uninduced hamster liver microsomes (25 Wg
protein/lane). E: Anti-P450 1A1: lane 1, TCDD-induced rlm (5 Wg
protein); lanes 2 and 4, S. haematobium and S. mansoni (30 Wg pro-
tein/lane), respectively and lane 3, blank. F: Anti-P450 IIIA: lane 1,
pregnenolone 16K-carbonitrile-induced rlm (5 Wg protein); lanes 2
and 4, S. haematobium and S. mansoni (30 Wg protein/lane), respec-
tively and lane 3, blank. G: Anti-P450 IVA: lane 1, clo¢brate-in-
duced rlm (5 Wg protein) and lanes 2^4, S. mansoni (25 Wg protein/
lane). H: Anti-P450 IVA: lane 1, clo¢brate-induced rlm (5 Wg pro-
tein) and lanes 2^4, S. haematobium (25 Wg protein/lane). I: Anti-
P450 2E1: lane 1, clo¢brate-induced rlm, lanes 2 and 3, uninduced
hamster liver microsomes and lanes 4^6, mouse lymphocytes (25 Wg
protein/lane). J: Anti-P450 2B1/2: lane 1, phenobarbital-induced rlm
(5 Wg protein), lane 2, uninduced hamster liver microsomes (25 Wg
protein), lane 3, blank and lane 4, mouse lymphocyte supernatant.
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4. Discussion
Using a variety of P450 substrates in functional assays
(summarised in Table 1) and immunoblotting with character-
ised anti-P450 proteins, it has been possible to identify P450
enzyme activities in extracts of either or both S. mansoni and
S. haematobium. A strong P450 2EI activity was identi¢ed in
S. mansoni that was higher or of a similar order to the speci¢c
activity of rat liver microsomes used as a positive control in
this study (Table 1). For one substrate (aminopyrine) the S.
mansoni activity was an order of magnitude higher than that
of the mammalian preparation. The limited volume of extract
available precluded a similar broad-spectrum study for S.
haematobium but assays with aminopyrine revealed an activity
greater than that with rat liver microsomes. Interestingly no
detectable activity was found in S. haematobium extracts when
assayed with NDMA as substrate, possibly suggesting a qual-
itative di¡erence in gene regulation between the schistosome
species or a very low level of expression in S. haematobium.
Either or both of these possibilities might result from adap-
tation to their di¡ering locations within the host’s body.
NDMA has been shown to be an acute hepatotoxin and a
potent carcinogen in many animal species and also potentially
in humans [16,17]. In experiments with human liver micro-
somes, it has been demonstrated that cytochrome P450 2EI
is the major enzyme responsible for the oxidative demethyla-
tion of NDMA at low substrate concentrations [18]. More-
over, P450 2E1 is considered to be a major catalyst respon-
sible for the metabolism of many low molecular weight
carcinogens and potentially toxic chemicals including ethanol,
nitrosamines, halogenated alkanes and aromatic compounds
[18^20]. These results using aminopyrine and NDMA as sub-
strates indicated that worm homogenate from S. mansoni and
to a lesser extent that of S. haematobium could metabolise
these substrates, due to the presence of P450 enzymes which
may be similar or identical to 2E1.
Using aniline, another potential P450 2E1 substrate, it was
not possible to detect hydroxylase activity in extracts of either
schistosomal species, suggesting that while a P450 2E1-like
demethylase activity was present in both worm species, this
did not extend to hydroxylase activity.
The presence of ethylmorphine- and benzphetamine-type
dealkylase activities adds further support for the existence of
a P450 system with proteins similar to 2EI in S. mansoni
worm extracts. However, due to sample limitation, no data
were obtained for this substrate with S. haematobium.
Investigation of possible P450 1A1/2 activity using ethoxy-
resoru¢n revealed that both S. mansoni and S. haematobium
were apparently totally de¢cient in this activity under assay
conditions which readily detected the same activity in induced
rat liver microsomes. Wardlaw et al. [10] showed that the
metabolism of ethoxyresoru¢n is associated with P450 1A1
and 1A2, with the 1A1 form metabolising ethoxyresoru¢n to
a much greater extent than 1A2 when both P450s are present.
P450 1A2 is a major constitutive enzyme in human liver and
has been identi¢ed as a key factor in the bioactivation of a
large number of environmental contaminants including a£a-
toxin, arylamines and dietary heterocyclic amines [21]. These
data indicate P450 1A1/2, or a close homologue, may not be
expressed in adult schistosomal worms. Alternatively, it is
possible that this form of P450 may need to be induced
with an appropriate inducing agent (such as TCDD or poly-
aromatic hydrocarbons) which are well known to upregulate
mammalian P450 1A1/2 [22]. Additional possibilities are that
other factors such as enzyme stability, the need for unique co-
factors or the presence of inhibitors in the worm extract,
somehow may have compromised these assays of activity.
P450 1A1 has also been shown to be highly inducible in ani-
mals treated with chemical inducers such as polycyclic aro-
matic hydrocarbons [22]. The constitutive levels of both these
P450 isozymes are low and normally represent less than 1% of
the total P450 protein content of livers in untreated, male or
female, rat liver.
The high assayable level of 2B1/2 activity in S. mansoni
worms suggests that because the P450 form (2B1/2) is usually
induced by administration of barbiturate compounds such as
phenobarbital [7] or steroids such as dexamethasone [22],
there may be P450 proteins that are uniquely expressed in
these schistosomes. The pentoxyresoru¢n deethylase reaction
is thought to be carried out by P450 2B1 and 2B2 and these
data imply that an analogous system may operate in S. man-
soni adult worms.
It has been reported that P450 IIIA can be induced by
steroids such as dexamethasone or pregnenolone-16K-carbo-
nitrile, as well as by phenobarbital and some antibiotics ;
members of this P450 family can also be developmentally
regulated [23^26]. As this activity was not detected in worm
extracts, it is not unreasonable to conclude that expression of
P450 IIIA could either be controlled by a developmentally
regulated switch or only be expressed in response to an ap-
propriate inducing signal and that such a regulatory mecha-
nism is shared by S. mansoni and S. haematobium.
The data produced in this study have not only demon-
strated that schistosomes possess a range of di¡erent P450
activities, but suggest that di¡erences in levels of expression
of P450 proteins between the parasites and their host may be
su⁄cient to allow new classes of anti-schistosomal drugs to be
developed. The expression patterns of other P450 subclasses,
their inducibility and their substrate speci¢cities also need
more rigorous investigation in future studies, but the present
data clearly imply that this strategy may have some merit.
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